Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news from the pharmaceutical sector.
Pfizer on Wednesday defended the effectiveness of its COVID-19 vaccine, saying it has saved more than 14 million lives worldwide, after U.S. President Donald Trump urged pharmaceutical companies to ju
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
PFE has shown great efforts in operational efficiencies, as observed in the richer profit margins, the expanding cash flows, and the healthier balance sheet. This is on top of its new pipelines/ partn
According to the Internal Revenue Service (IRS), passive income generally includes earnings from rental activity or any trade, business, or investment in which the individual does not materially parti
Study to explore the palazestrant-atirmociclib combination in approximately 35 patients with initiation anticipated in H2 2025 Results to inform potential pivotal Phase 3 trial of novel combination in
A buoyant stock market that keeps reaching new heights is great for the stocks already in our brokerage accounts. After a few strongly positive years, though, finding stocks that pay high dividend yie
Pfizer trades above key SMAs with a golden cross, while new drugs and cost cuts drive growth despite looming headwinds.
Healthcare stocks haven't moved since the April lows. As contrarian investors, this neglect piques our interest.
President Donald Trump called on pharmaceutical companies to "justify the success" of their Covid drugs days after the FDA set new limits on who can receive vaccines for the virus. Trump last week fir
Pfizer (PFE 0.65%) has become the dividend investor's siren song. With shares down 31% over the past five years and a current yield of 7%, the pharmaceutical giant offers one of the juiciest payouts i
Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge d

3 No-Brainer Stocks to Buy Right Now

06:45am, Sunday, 31'st Aug 2025
Some decisions require lengthy deliberations and extensive analysis. Others don't.
If you're in the market for some promising dividend-paying stocks, good for you! They can be powerful components in your portfolio, ideally delivering not only regular income but also, over time, appr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE